To include your compound in the COVID-19 Resource Center, submit it here.

Primate predictions

Illumina’s PrimateAI algorithm improves identification of pathogenic mutations

A team at Illumina Inc. (NASDAQ:ILMN) has developed an AI algorithm that will help identify pathogenic mutations from genome sequencing analyses by including non-human primate data in the training data set, and the approach could be used to identify new targets for personalized therapies.

The deep neural learning network, named PrimateAI, was

Read the full 528 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE